RxDoctor Payments Data

Mohammed Aslam, MD

Advanced Heart Failure and Transplant Cardiology · San Antonio, TXNPI 1811230238

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.2%. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in TX, where the typical reported total is $11,093.

$8,281in general payments, 2019–2025

Across 66 payments — averaging $125.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$1K
  • Medtronic$1K
  • Inari Medical, Inc.$1K
  • Abiomed$1K
  • Boston Scientific$994
  • Abbott$686
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$91311%
  • Travel & lodging$3,80746%
  • Food & beverage$3,56143%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,281 in reported general payments places this provider in the 45th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.

See all advanced heart failure and transplant cardiology providers in Texas

Medicare billing

Part B allowed, 2024
$95,669
Medicare patients
194
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan65$70,523
FarxigaDapagliflozin Propanediol35$49,615
JardianceEmpagliflozin28$35,086
EliquisApixaban36$32,636
OzempicSemaglutide16$18,632
Repatha SureclickEvolocumab13$7,601
Mexiletine Hcl12$672
Spironolactone86$643
Metoprolol Succinate42$641
Ezetimibe27$303
Atorvastatin Calcium47$300
Rosuvastatin Calcium30$239
ClopidogrelClopidogrel Bisulfate21$225
Carvedilol29$87
Furosemide18$38

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →